International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01)

Despite recent advances in breast cancer research, we still know little about the mechanisms that lead to metastatic breast cancer (MBC). However, treatment options for patients have increased based on results of recent randomized clinical trials in this setting. Today we have much hope, yet many questions remain unanswered. Conducting a fully academic and international study such as AURORA is very challenging, yet ever more crucial to advancing knowledge about MBC.

Automated summary

Although progress has been made in breast cancer research, the mechanisms behind metastatic breast cancer (MBC) are still poorly understood. However, recent clinical trials have expanded treatment options for patients in this area. While many questions remain unanswered, conducting an academic and international study like AURORA is crucial for advancing knowledge about MBC.